It is intriguing that the nano-LC-PRM/HRMS assay also revealed that cisplatin but not carboplatin stimulated HMGB1 secretion from A549 NSCLC cells (Figure 2) as these chemotherapeutic agents are typically thought to have identical modes of action. Here, HMGB1 is linked to non-small cell lung carcinoma.